Antiplatelet Premedication for Stent-Assisted Coil Embolization of Intracranial Aneurysms: Low-Dose Prasugrel vs Clopidogrel

Ticagrelor therapy and atrioventricular block: Do we need to worry?

(2017) Elia De Maria et al.   World Journal of Clinical Cases

Association between Postprocedural Infarction and Antiplatelet Drug Resistance after Coiling for Unruptured Intracranial Aneurysms

(2016) M.S. Kim et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Prophylactic Antiplatelet Medication in Endovascular Treatment of Intracranial Aneurysms: Low-Dose Prasugrel versus Clopidogrel

(2016) E.J. Ha et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Another side effect of ticagrelor: Atrial fibrillation

(2016) Nixiao Zhang et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Insufficient platelet inhibition and thromboembolic complications in patients with intracranial aneurysms after stent placement

(2016) Hongchao Yang et al.   JOURNAL OF NEUROSURGERY

Prasugrel versus clopidogrel in stent-assisted coil embolization of unruptured intracranial aneurysms

(2016) Jacques Sedat et al.   INTERVENTIONAL NEURORADIOLOGY

Relationship between low response to clopidogrel and periprocedural ischemic events with coil embolization for intracranial aneurysms

(2015) Takumi Asai et al.   Journal of NeuroInterventional Surgery

Standard vs Modified Antiplatelet Preparation for Preventing Thromboembolic Events in Patients With High On-Treatment Platelet Reactivity Undergoing Coil Embolization for an Unruptured Intracranial Aneurysm

(2015) Gyojun Hwang et al.   JAMA Neurology

Differences in Ischemic and Hemorrhagic Recurrence Rates among Race-Ethnic Groups in the PRoFESS Secondary Stroke Prevention Trial

(2014) Conrado J. Estol et al.   International Journal of Stroke

Stent-Assisted Coiling versus Coiling Alone in Unruptured Intracranial Aneurysms in the Matrix and Platinum Science Trial: Safety, Efficacy, and Mid-Term Outcomes

(2013) S. W. Hetts et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Safety and efficacy of ticagrelor for neuroendovascular procedures. A single center initial experience

(2013) Ricardo A Hanel et al.   Journal of NeuroInterventional Surgery

Stent-Assisted Coiling of Intracranial Aneurysms

(2013) Nohra Chalouhi et al.   STROKE

CYP2C19 genotypes and their impact on clopidogrel responsiveness in percutaneous coronary intervention

(2013) Melissa Mejin et al.   International Journal of Clinical Pharmacy

Prevention of stent thrombosis with reduced dose of prasugrel in two patients undergoing treatment of cerebral aneurysms with pipeline embolisation devices

(2012) G Morgan Jones et al.   Journal of NeuroInterventional Surgery

Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures

(2012) S Hassan Akbari et al.   Journal of NeuroInterventional Surgery

Prasugrel is effective and safe for neurointerventional procedures

(2012) William R Stetler et al.   Journal of NeuroInterventional Surgery

Novel use of prasugrel for intracranial stent thrombosis

(2011) T. M. Leslie-Mazwi et al.   Journal of NeuroInterventional Surgery

Preinterventional Clopidogrel Response Variability for Coil Embolization of Intracranial Aneurysms: Clinical Implications

(2010) H.-S. Kang et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Thromboembolic Complications of Elective Coil Embolization of Unruptured Aneurysms

(2010) Gyojun Hwang et al.   NEUROSURGERY

Effect of Age on the Pharmacokinetics and Pharmacodynamics of Prasugrel during Multiple Dosing

(2009) David S. Small et al.   DRUGS & AGING

Population Pharmacokinetic Analyses to Evaluate the Influence of Intrinsic and Extrinsic Factors on Exposure of Prasugrel Active Metabolite in TRITON-TIMI 38

(2009) Rebecca E. Wrishko et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

(2009) Lars Wallentin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Stent-Assisted Coiling of Intracranial Aneurysms

(2009) Michel Piotin et al.   STROKE

Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) study

(2008) Koon-Hou Mak et al.   AMERICAN HEART JOURNAL